Rexulti® (brexpiprazole) Uses, Dosing, Side Effects, and Savings

What Rexulti® Is and How It Works

Rexulti (brexpiprazole) is an oral atypical antipsychotic. It is approved for adults with schizophrenia and as adjunctive therapy to antidepressants for major depressive disorder. In the United States, it is also approved for agitation associated with dementia due to Alzheimer’s disease. Many people compare rexulti cost across pharmacies to manage ongoing treatment budgets.

YouDrugstore is a licensed Canadian pharmacy based in Manitoba; licensed pharmacists review prescriptions before dispensing, and you can order online or by phone with customer-service chat during posted hours.

Brexpiprazole modulates dopamine and serotonin signaling. It is a partial agonist at dopamine D2 and serotonin 5‑HT1A receptors and an antagonist at 5‑HT2A receptors. This balance may help stabilize mood, reduce psychotic symptoms, and support antidepressant response. Tablets are taken once daily, with or without food.

Common treatment goals include symptom control in Schizophrenia and improved depressive response in Major Depressive Disorder. Prescribers individualize dosing based on indication, response, and tolerability.

Dosage and Usage

• Form and route: Oral tablets taken once daily, with or without food.
• Starting dose for adjunctive MDD: 0.5–1 mg once daily; increase gradually to 2 mg/day as the usual target.
• Maximum dose for adjunctive MDD: Up to 3 mg/day based on response and tolerability.
• Starting dose for schizophrenia: 1 mg/day on days 1–4, then 2 mg/day on days 5–7, then 4 mg/day on day 8.
• Maintenance for schizophrenia: 2–4 mg/day; do not exceed 4 mg/day.
• Agitation associated with Alzheimer’s dementia (US): Start 0.5 mg/day for 7 days, then 1 mg/day for 7 days; may increase to 2 mg/day; some patients may need up to 3 mg/day.
• Missed dose: Take the missed dose when remembered unless it is close to the next dose; do not double up. After several missed days, prescribers may retitrate.
• Best time to take: Choose a consistent time each day. Morning works for many; evening may suit patients who feel drowsy.
• Drug interactions: Dose changes may be needed with strong CYP3A4 or CYP2D6 inhibitors/inducers, or with combined 3A4+2D6 inhibition.
• Hepatic/renal impairment: Lower dose or slower titration may be required based on clinical guidance.
• Discontinuation: Abruptly stopping can lead to symptom return or withdrawal-like effects; tapering plans are typically used.

• Store at 20–25°C (68–77°F); short excursions 15–30°C (59–86°F) are acceptable.
• Keep tablets dry and in the original container with the label.
• Protect from excessive heat, moisture, and direct sunlight.
• For travel, keep medicine in carry-on baggage with a copy of your prescription.
• Do not store in a bathroom or car glove box where temperatures fluctuate.

Benefits and Savings

Rexulti can improve positive and negative symptoms in schizophrenia and help reduce residual depressive symptoms when added to an antidepressant. Once-daily dosing supports adherence. It is available across a range of strengths to allow careful titration.

Ordering through Canadian pricing can reduce monthly spending. Many customers see 60–80% savings versus typical US retail. Multi-month supplies and occasional bulk promotions can further reduce per‑month costs, and you can set gentle reorder reminders in your account to avoid running out.

To help manage budget planning, you can review the rexulti coupon options on our Promotions page when available.

We work with licensed, vetted international partner pharmacies to provide authentic brand medicines, a wide selection, and competitive pricing.

Side Effects and Safety

• Common effects: weight gain, increased appetite, akathisia (inner restlessness), anxiety, headache, dizziness, somnolence, fatigue, tremor, constipation, nausea, insomnia.
• Metabolic changes: possible increases in blood glucose and lipids; periodic monitoring is often used.
• Orthostatic hypotension: lightheadedness on standing may occur, especially during titration.
• Extrapyramidal symptoms: restlessness, rigidity, or tremor can appear and may require dose adjustments.
• Impulse‑control issues: rare urges such as gambling or compulsive shopping have been reported with dopamine modulators.

Serious risks include neuroleptic malignant syndrome, tardive dyskinesia, seizures, leukopenia/neutropenia, and cerebrovascular events in elderly patients with dementia. Antidepressant‑class labeling warns of increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults. There is an increased mortality warning in older adults with dementia‑related psychosis. Avoid alcohol that can worsen sedation; see our article on Abilify And Alcohol Risks And Safety Tips for general guidance about antipsychotics and alcohol. For broader adverse‑effect context, read Abilify Side Effects What To Watch For And How To Manage.

Onset Time

For schizophrenia, some patients notice early changes within 1–2 weeks of titration. Broader improvements often emerge over 4–6 weeks at a stable dose.

As adjunctive therapy for major depressive disorder, initial improvement may appear within 1–2 weeks, with fuller effects by weeks 4–6 as the dose is optimized and antidepressant treatment continues.

For agitation in Alzheimer’s dementia, benefits can begin after the first two weeks of dose increases, with continued gains through 4–8 weeks. Individual timelines vary.

Compare With Alternatives

Aripiprazole is another dopamine partial agonist with a long generic track record. Compared to brexpiprazole, aripiprazole may have a higher rate of akathisia in some patients but can be more cost‑effective due to generic availability.

Brand Abilify® is the originator aripiprazole. Patients stabilized on Abilify may switch within the class under prescriber guidance if side effects or response differ.

Latuda® (lurasidone) is often used for schizophrenia and bipolar depression. It must be taken with food and has a distinct side‑effect profile, including less metabolic impact for some patients.

Therapy selection considers diagnosis, prior response, side effects, and cost. For mood‑focused resources, you can also explore our article Fluoxetine For Anxiety How It Boosts Mood And Reduces Worry.

Combination Therapy

• Adjunctive MDD: Combine with an SSRI or SNRI when antidepressant response is incomplete; monitor for activation or sedation.
• Schizophrenia: May be used alongside mood stabilizers or antidepressants when clinically indicated.
• Dose adjustments: When used with strong CYP3A4/2D6 inhibitors or inducers, prescribers often adjust brexpiprazole dose to maintain exposure.
• Reduce overlapping side effects: If combined with sedatives, monitor for excess drowsiness and falls risk.

Patient Suitability and Cost-Saving Tips

Rexulti may suit adults with schizophrenia or those needing adjunctive support for major depressive disorder. It is not approved for pediatric use for these indications. Older adults with dementia‑related psychosis have increased mortality risk, though the US label includes agitation in Alzheimer’s dementia with careful monitoring.

Those with a history of seizures, significant cardiovascular disease, diabetes, or lipid disorders may need closer monitoring. Dose changes may be prudent in moderate to severe hepatic or renal impairment. Discuss pregnancy planning and breastfeeding with a clinician. Avoid abrupt discontinuation when possible.

To help manage month‑to‑month spending, consider longer supplies to lower the rexulti cost per month. You can turn on reorder reminders in your account and compare strengths to match the prescribed dose while minimizing waste. Our pricing reflects Canadian rates, which often run lower than typical US retail.

Authoritative Sources

Otsuka/Lundbeck Rexulti US product information

Health Canada Drug Product Database: brexpiprazole

US FDA Prescribing Information and Medication Guide

Order Rexulti® from YouDrugstore: add to cart, upload your prescription, and we ship with prompt, express shipping.

This content is educational and does not replace advice from your healthcare professional. Always follow your prescriber’s directions for diagnosis, treatment, and monitoring.